SP100 expression modulates ETS1 transcriptional activity and inhibits cell invasion

被引:42
作者
Yordy, JS
Li, RZ
Sementchenko, VI
Pei, HP
Muise-Helmericks, RC
Watson, DK
机构
[1] Med Univ S Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA
[3] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA
[4] Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA
[5] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA
关键词
Ets; transcription; invasion; SP100; MMP; UPA;
D O I
10.1038/sj.onc.1207891
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ETS1 transcription factor is a member of the Ets family of conserved sequence-specific DNA-binding proteins. ETS1 has been shown to play important roles in various cellular processes such as proliferation, differentiation, lymphoid development, motility, invasion and angiogenesis. These diverse roles of ETS1 are likely to be dependent on specific protein interactions. To identify proteins that interact with ETS1, a yeast two-hybrid screen was conducted. Here, we describe the functional interaction between SP100 and ETS1. SP100 protein interacts with ETS1 both in vitro and in vivo. SP100 is localized to nuclear bodies and ETS1 expression alters the nuclear body morphology in living cells. SP100 negatively modulates ETS1 transcriptional activation of the MMP1 and uPA promoters in a dose-dependent manner, decreases the expression of these endogenous genes, and reduces ETS1 DNA binding. Expression of SP100 inhibits the invasion of breast cancer cells and is induced by Interferon-alpha, which has been shown to inhibit the invasion of cancer cells. These data demonstrate that SP100 modulates ETS1-dependent biological processes.
引用
收藏
页码:6654 / 6665
页数:12
相关论文
共 69 条
[41]   Cancer invasion: Watch your neighbourhood! [J].
Quaranta, V ;
Giannelli, G .
TUMORI JOURNAL, 2003, 89 (04) :343-348
[42]   Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data [J].
Ramakers, C ;
Ruijter, JM ;
Deprez, RHL ;
Moorman, AFM .
NEUROSCIENCE LETTERS, 2003, 339 (01) :62-66
[43]   TRANSCRIPTION FACTOR PEA3 PARTICIPATES IN THE INDUCTION OF UROKINASE PLASMINOGEN-ACTIVATOR TRANSCRIPTION IN MURINE KERATINOCYTES STIMULATED WITH EPIDERMAL GROWTH-FACTOR OR PHORBOL-ESTER [J].
RORTH, P ;
NERLOV, C ;
BLASI, F ;
JOHNSEN, M .
NUCLEIC ACIDS RESEARCH, 1990, 18 (17) :5009-5017
[44]  
Rutter JL, 1998, CANCER RES, V58, P5321
[45]   Androgen receptor-Ets protein interaction is a novel mechanism for steroid hormone-mediated down-modulation of matrix metalloproteinase expression [J].
Schneikert, J ;
Peterziel, H ;
Defossez, PA ;
Klocker, H ;
deLaunoit, Y ;
Cato, ACB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (39) :23907-23913
[46]   The PML nuclear bodies: actors or extras? [J].
Seeler, JS ;
Dejean, A .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1999, 9 (03) :362-367
[47]   Interaction of SP100 with HP1 proteins: A link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment [J].
Seeler, JS ;
Marchio, A ;
Sitterlin, D ;
Transy, C ;
Dejean, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (13) :7316-7321
[48]   Ets target genes: past, present and future [J].
Sementchenko, VI ;
Watson, DK .
ONCOGENE, 2000, 19 (55) :6533-6548
[49]   ETS2 function is required to maintain the transformed state of human prostate cancer cells [J].
Sementchenko, VI ;
Schweinfest, CW ;
Papas, TS ;
Watson, DK .
ONCOGENE, 1998, 17 (22) :2883-2888
[50]  
STACEY KJ, 1995, MOL CELL BIOL, V15, P3430